WP16302 A Bioequivalence Study Comparing Ganciclovir From the Valganciclovir Syrup Formulation and the Commercial Valganciclovir 450mg Tablet (Valcyte®) at a Dose of 900mg in Kidney Transplant Recipients
Clinical trial NCT00275314 · TERMINATED
Trial details
- NCT number
- NCT00275314
- Sponsor
- University of Pittsburgh
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2006-02-01
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.